Brind.

RSI reading of 26.7 indicates oversold territory for Soleno Therapeutics.

1 report, 1 independent Updated Aug 19

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

RSI Soleno Therapeutics (United States)

Keep exploring

The entities involved

RSI
company based in Latvia
- Trump's pledge to unleash oil and gas is reported to benefit stocks, involving Landstar System.Sun 02:33
- RSI was showing a reading of 28.51 on September 1, 2025, indicating that the company was in oversold territory.Sun 02:19
Soleno Therapeutics (United States)
company in Redwood City, United States
- AI stocks are benefiting from Trump-era tariffs, and Brian Schwartz maintained an Outperform rating on Workday on September 5th.Sun 01:33

Coverage

Newest first; wire copies grouped

Aug 19ZacksDown 21.7% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround Soleno Therapeutics, Inc. (SLNO) has been on a downward spiral lately with significant selling pressure. After